China Pharma Pure Powder manufacturer

Anti COVID 19 Veterinary Raw Materials USP grade Ivermectin 99%

Product Details:
Place of Origin: Xi'An,China
Brand Name: wango
Certification: USP, BP
Model Number: W-0011
Payment & Shipping Terms:
Minimum Order Quantity: 1kilogram will be sent by Expresses
Price: FOB price 190-240usd/kg
Packaging Details: 25kilogram /drum
Delivery Time: 3-5 working days
Payment Terms: L/C, T/T, Western Union
Supply Ability: 1000kilogram every month

Detail Information

Function: Anti-COVID-19 Appearence: White Fine Powder
Name: Ivermectin
High Light:

Anti COVID 19 Veterinary Raw Materials

,

Veterinary Raw Materials Ivermectin 99%

Product Description

Ivermectin 99%  Anti-intestinal parasites Raw Powder USP  grade Cas 70288-86-7 manufacturer for pets and vets and human !

 

 

COA  

 

Product

Ivermectin

 

Testing Item

Standard

Result

Solubility

Partically insoluble in water, freely soluble in methylene chloride, soluble in alcohol

Complies

Identification

Ivermectin

1. IR-Should comply

2. HPLC-Should comply

Complies

Appearance of solution

Solution is clear ≤ BY7

Complies

Specific Optical Rotation

-17° ~ -20°

-18.5°

Related Substance

a).Impurity (1.3<RRT<1.5) ≤ 2.5%

b).Any other specified impurity ≤ 1.0%

c).Any unspecified impurity ≤ 0.20%

d).Total impurities ≤ 5.0%

a). 2.1%

b).A:0.4%,E:0.2%,H:0.1%,J1:0.4%,J2:0.1%, F or I(RRT0.86):0.1%,For I(RRT1.56):0.1%

c).RRT1.11:0.05%

d).3.6%

Ethanol

≤ 5.0%

3.7%

Formamide

≤ 3.0%

2.3%

Heavy Metal

≤ 0.002%

<0.002%

Moisture

≤ 1.0%

0.08%

Sulfated Ash

≤ 0.1%

0.02%

Content (H2B1a+H2B1b)

95.0% ~ 102.0% (Ivermectin)

96.8%

H2B1a/(H2B1a+ H2B1b)

≥ 98.0%

98.2%

 

Function :

 

Ivermectin is gaining worldwide attention. First, its discoverer, William Campbell, shared the 2015 Nobel Prize in Physiology with Satoshi Omura of Japan and Tu Youyou of China for their work on parasite resistance. Over the years, preclinical studies have consistently reported that ivermectin inhibits the proliferation and metastasis of cancer cells, promotes the death of cancer cells, and has therapeutic effects on conventional chemotherapy resistant cancer cells, as well as synergistic effects when used in combination with chemotherapy drugs or targeted drugs. Moreover, model dose studies have shown that the anticancer dose is quite low in normal cytotoxicity (Juarez M et al. 2018). These are not the focus of this article. The focus of this article is "The Frontline COVID-19 Intensive Care Alliance (FLCCC), Speaking before the Senate Homeland Security and Governmental Affairs Committee on early treatment of outpatient COVID-19, Dr. Pierre Kory, Chairman of the Frontline COVID-19 Critical Care Alliance, To request government agencies to assess their clinical data on ivermectin in the treatment and protection against COVID-19novel Coronavirus infections and to provide a treatment recommendation or guideline to the public.

 

On the morning of December 8, the Senate Homeland Security and Governmental Affairs Committee held "Important Steps for a COVID-19 Solution: Dr Pierre Kory, president of the Frontline COVID-19 Intensive Care Alliance (FLCCC), appeared as a witness at the "Outpatient Early Treatment" hearing and called on the government to accelerate the analysis of data on the efficacy of ivermectin in treating and protecting against COVID-19. Dr Kory believes there is a large body of data showing that ivermectin can prevent COVID-19 from worsening in those with early symptoms, including progression to a severe immune-inflammatory response, and even help critically ill patients recover. "I'm a lung specialist and ICU specialist, and all I'm doing right now is taking care of COVID-19 patients, and when they get to the ICU, they can't breathe," Dr. Kory said. It's almost impossible for me to save most patients." Kory went on to say that the FLCCC consortium has collected the results of more than 20 clinical studies, more than 10 of which were randomized controlled trials, with clinical evidence that far exceeds the FDA's compassionate use authorization. The NATIONAL Department of Health and the National Health System must quickly review these data and give the public treatment guidelines and recommendations. But Facebook and other social media refused to disseminate the FLCCC's views and recommendations on ivermectin, and at one point even shut down the FLCCC's page. FLCCC also held a press conference on December 4 to ask the federal government for help in taking action to end the pandemic. But no federal government agency, such as the Centers for Disease Control and Prevention (CDC) or the National Institutes of Health (NIH), was interested in the clinical data on ivermectin provided by FLCCC, and none of the major U.S. media outlets reported on FLCCC's request.

 

Application 

 

Bacterin is widely used in gastrointestinal nematodes, lungworms and parasitic arthropods of cattle, sheep, horses and pigs, intestinal nematodes of dogs, ear mites, scabies, heartworms and microfilariae, as well as gastrointestinal nematodes and ectoparasites of poultry.

 

(l) Ivermectin for cattle and sheep by 0.2mg/kg orally or subcutaneously; The insecticidal rate was 97-100% against hemocellus, Osteriasis, Gucyperus, Strongyloides trichostrongyloides (including Strongyloides escherichia), rounded nematodes, stomatodes, nematodes, nematodes, nematodes and chabot sheep adults and stage 4 larvae. These doses are also effective on arthropods, such as maggots (cowskin fly, leatherskin fly, rabid fly), mites (bovine scabies, pruritic mite) and lice (bovine palate lice, bovine blood lice and sheep palate lice). Ivermectin is less effective on chewing louse (trichoderma) and sheep tick fly. Ivermectin is also highly effective against ticks and flies that reproduce in their faeces. Although the drug cannot kill or dismember ticks immediately, it can affect feeding, molting and oviposition, thus reducing the reproductive capacity of ticks. The above phenomenon was most obvious in ticks 5 days after a single subcutaneous injection of 0.2mg/kg or daily feeding of low concentration (0.01mg/kg). According to 0.2 mg/kg dose a subcutaneous injection of breeding in the feces of flies also have certain control effect, cattle use 9 days after their faeces plane flies, autumn housefly larvae cannot develop adult, another 5 days, due to the deformity of pupa and adult mature process is inhibited, thus greatly reducing the flies breeding of blood fly (one blood fly) in the dose, similar after 4 weeks.

 

(2) Internal administration of 0.2mg/kg ivermectin was highly effective (95%-100%) against adults and stage 4 larvae of the following genera of Macrophyllodes and Microphyllodes. For example, large round nematodes (Common round nematodes, Rounded nematodes equis, rounded nematodes apentatus), roundworms (parascaris equis), pinworms (Equis trichoderma), stomach worms (megadodes, Trichoderma), small intestinal nematodes (Trichoderma Ersonii, Rounded nematodes Weyseri), lungworms (nematodes angelica), etc. Although a dose of 0.2mg/kg was also limited for the three kinds of maggots of the horse stomach fly, the microfilariae of the worm onococci that cause skin injury, and the third stage larvae of the stomach nematode, the optimal treatment was a second dose of the above dose one month later.

 

Of particular significance is that the recommended dose of ivermectin (0.2mg/kg) is about 99% effective in the treatment of mesenteric artery damage caused by the early and the fourth stage larvae of C. elegans in the transitional stage, usually 2 days after the treatment, the symptoms were significantly relieved, and all the symptoms disappeared in about 28 days.

 

(3) Intramuscular injection of 0.3mg/kg ivermectin showed broad-spectrum insecticidal activity in pigs. Such as ascaris suis, Strongylodes rubiformis, Strongylodes langerii, trichocephalus, oesophageal mouth nematodes, metastrongylodes, and adult and immature nematodes with ententate, the removal rate was 94% ~ 100%, and it was also very effective against trichinella spiralis in intestinal tract (not in muscle). These methods also have good control effect on pig blood louse and pig scabies mite.

 

(4) dogs and cats abroad have special dosage form (according to 6 ~ 12μg/kg) for the prevention and control of dog filariasis microfilariasis infection, China can try 50μg/kg internal treatment of filariasis microfilariasis infection (adult ineffective). Clinical trials have confirmed that high dose of ivermectin has high efficacy against a variety of canine parasites, such as 50μg/kg subcutaneous injection of C. Canis, C. brasiliensis and C. Canis, 100μg/kg against C. Canis and 200μg/kg against C. Canis adults and larvae of stage IV. The efficacy of 200μg/kg subcutaneous injection was 69%, while that of oral administration was 95%. This product once subcutaneously injected, the dog parasitic in the lungs of capillus aerosinophilus (200μg/kg), Osselle nematode (400μg/kg) also has excellent effect. The efficacy of 200μg/kg to strongyloides faecalis (except for stage 3 larvae) was 95% ~ 100%. Ivermectin is also effective for some arthropod infections in dogs and cats. Subcutaneous injection of 200μg/kg dose in dogs and cats can rule out infection of ear mite, scabies mite and canine pulmonary acaroid mite after two weeks. At 300μg/kg, two doses (2 weeks apart) were also effective against The infection. The best treatment for demodex in dogs is 600μg/kg subcutaneous injection at an interval of 7 days. Use it 5 times.

 

(5) It is highly effective to take 200 ~ 300μg/kg orally or subcutaneously for the treatment of domestic nematodes such as ascaris gallicoris and closed capillaria as well as the arthropod parasitised by poultry, such as Genicarus mutatus. However, this product has no effect on chicken nematodes.

 

(6) Reindeer to reindeer Oedemagenatarandi infection, according to the dosage of cattle (200μg/kg) subcutaneous injection can be.

 

 

Although ivermectin is only an fda-approved antiparasitic drug, many invitro invitro studies have shown that ivermectin can inhibit the replication of many RNA viruses, These are Dengue, Zika, Yellow fever, West Nile, Chikungunya and Semliki Forest viruses Sindbis Virus, Porcine reproductive and respiratory syndrome Virus.

 

A paper by Australian scientist Leon Caly et al. (Caly L, et al.2020) has been published in Antiviral Research on 3 April this year. Ivermectin, a sarS-COV-2 suppressor, can reduce viral nucleic acid (RNA) in cells by 5,000 times between two hours and 48 hours after infection. Since ivermectin is listed in the Who Essential Medicine Standard List and is widely used, further clinical studies on its potential benefits to humans are necessary. In fact, as of December 11, there were 43 clinicaltrials registered on clinicaltrials.gov (author's query December 12, 2020).

 

In the invitro experiment, 5μM ivermectin was added to SARS-COV-2 infected Vero-HSLAM cell cultures in a petri dish. The supernatant and cell precipitates were harvested at day 0 to 3, and the replication of SARS-CoV-2RNA was analyzed by RT-PCR. It was found that 24 hours after treatment with ivermectin, the amount of viral nucleic acid (RNA) invading cells decreased by 99.8%. By 48 hours, compared with the reference, the viral nucleic acid treated with ivermectin was reduced by about 5000 times, indicating that 48 hours after the intervention of ivermectin, all viral material basically disappeared. Because the trials were conducted in vitro, ivermectin was administered at doses 60 or 10 times higher than the serum drug concentrations observed at conventional or maximum doses for the treatment of parasitic diseases such as river blindness. For this reason, some people believe that the dose required for the treatment of COVID-19 with ivermectin cannot reach the dose used in vitro experiments. Therefore, they believe that any efforts to study it are a waste, but it gives the public a false sense of hope, and it is not recommended to use ivermectin to treat COVID-19. Others, citing the current surge in COVID-19 cases or the sense of urgency of hospital withdrawal, say ivermectin can be widely used as long as it is relatively safe, even without rigorous clinical trial data supporting its efficacy against COVID-19.

Anti COVID 19 Veterinary Raw Materials USP grade Ivermectin 99% 0

 

F.A.Q

1:Can I get some samples before bulk order?
Most products provide free samples, but the shipping cost be paid by customers.

2: What's your MOQ?
For the high value product, our MOQ starts from 10g,100g and 1kg.

3: Which kind of payment terms do you accept?
PI will be sent first after confirmation of order,enclosed our bank information.Payment by T/T, Western Union, L/C, Alibaba trade assurance, Cashapp,Moneygram or Bitcoin.

4.How to place an order?
You can contact me through Trademanager, WhatsApp, Skype Online and other contact methods, tell me the product and quantity you need, and then we will give you a quote. If you choose one of the above payment methods, we will arrange the delivery for you.

5:How about your delivery time?
A: Generally, it will take 3 to 5 days after receiving your advance payment.

6:How do you treat quality complaint?
A:First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.

 

 

Get in touch with us

Enter Your Message

You Might Be Into These